DSP Healthcare Fund · Regular · Growth
NAV
₹46.8320
as of 13 Nov 2026
Expense Ratio
2.04%
AUM
₹3,721 Cr
Lumpsum returns (CAGR)
- 1Y
- +18.61%
- 3Y
- +20.13%
- 5Y
- +15.60%
- Since Inception
- +21.43%
SIP returns (XIRR)
- 1Y
- +29.16%
- 3Y
- +15.70%
- 5Y
- +18.88%
- Since Inception
- +20.51%
Returns calculated from 12 November 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Nov 2021 – Nov 2026)
A ₹5,000 monthly SIP for the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,75,349 today — ₹3,00,000 invested, 18.9% XIRR.
₹3,00,000
Invested
₹4,75,349
Value today
18.9%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹2,06,454 today (15.6% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2021 would still hold ₹15,89,190.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹4,75,349 in this fund vs ₹3,87,935 in the benchmark — outperformance of ₹87,414.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Nov 2021 – Nov 2026) (4 Jun 2024) would be ₹1,48,659 today (1.49×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.93
Sharpe Ratio
+0.12
Alpha
0.49
Beta
0.95
Sortino
12.04%
Std Dev
-12.50%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology66.01%
- Healthcare Services20.81%
- Healthcare Equipment & Supplies9.00%
- Insurance1.02%
Each sector links to the mutual funds most exposed to it.
Thinking about DSP Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Apollo Hospitals Enterprise Limited7.89%
- 2Ipca Laboratories Limited7.49%
- 3Cipla Limited7.40%
- 4Sun Pharmaceutical Industries Limited7.32%
- 5Gland Pharma Limited6.61%
- 6Sai Life Sciences Limited6.17%
- 7Globus Medical Inc5.36%
- 8Alkem Laboratories Limited4.73%
- 9Divi'S Laboratories Limited4.41%
- 10Cohance Lifesciences Limited3.82%
What this fund does
DSP Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
DSP Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by DSP Mutual Fund. The fund has been operational for over 8 years. It manages assets worth ₹3,721 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 2.04%.